GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Dividend Yield %

Ablynx NV (XBRU:ABLXS) Dividend Yield % : 0.00% (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Ablynx NV Dividend Yield %?

As of today (2024-06-20), the Trailing Annual Dividend Yield of Ablynx NV is 0.00%.

The historical rank and industry rank for Ablynx NV's Dividend Yield % or its related term are showing as below:

XBRU:ABLXS's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.64
* Ranked among companies with meaningful Dividend Yield % only.

Ablynx NV's Dividend Payout Ratio for the six months ended in Dec. 2017 was 0.00.

As of today (2024-06-20), the Forward Dividend Yield % of Ablynx NV is 0.00%.

Ablynx NV's Dividends per Share for the six months ended in Dec. 2017 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Ablynx NV Dividend Yield % Historical Data

The historical data trend for Ablynx NV's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Dividend Yield % Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ablynx NV's Dividend Yield %

For the Biotechnology subindustry, Ablynx NV's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Dividend Yield % falls into.



Ablynx NV Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Ablynx NV  (XBRU:ABLXS) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Ablynx NV Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines